Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: A phase II study

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1687-1692

  Chen, Li Kun ^a   Huang, He ^a   Liao, Hai ^a   Liu, Guo Zhen ^a   Zeng, Yin Duo ^a   Dinglin, Xiao Xiao ^a   Xu, Guang Chuan ^a   Wei, Wei Dong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Brain metastases (BM); Chemotherapy; Small cell lung cancer (SCLC); Thoracic radiotherapy; Whole brain radiotherapy (WBRT)

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG ERUPTION; DRUG INDUCED HEADACHE; ESOPHAGITIS; FEMALE; HUMAN; KIDNEY DYSFUNCTION; LEUKOPENIA; LUNG SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SURVIVAL TIME; THROMBOCYTOPENIA; TOXIC HEPATITIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMALL CELL LUNG CARCINOMA;

EID: 84872807030     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0040-8     Document Type: Article

References (27)

1. Pedersen AG. Diagnosis of CNS-metastases from SCLC. In: Hansen HH, editor. Lung cancer: basic and clinical aspects. Dordrecht: Martinus Nijhoff; 1986. p. 153-82.
2. Bunn PA, Nugent JL, Matthews M. Central nervous system metastases in small cell bronchogenic carcinoma. Semin Oncol. 1978;5:314-22.
3. Seute T, Leffers P, ten Velde GP, et al. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer. 2004;100:801-6.
4. Postmus PE. Brain metastases from small cell lung cancer: Chemotherapy, radiotherapy, or both? Semin Radiat Oncol. 1995;5: 69-73.
5. Bohlen G, Meyners T, Kieckebusch S, et al. Short-course wholebrain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC). Clin Neurol Neurosurg. 2010;112:183-7.
6. Lee JS, Murphy WK, Glisson BS, et al. Primary chemotherapy of brain metastasis in small-cell lung cancer. J Clin Oncol. 1989;7: 916-22.
7. Seute T, Leffers P, Wilmink JT, et al. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. J Clin Oncol. 2006;24:2079-83.
8. Korfel A, Oehm C, Von J, et al. Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation: a multicentre phase II study. Eu J Cancer. 2002;38:1724-9.
9. Veslemes M, Polyzos A, Latsi P, et al. Outcome of patients with brain metastases after combined modality therapy in small cell lung cancer (SCLC): a retrospective study. J Chemother. 1995;7: 460-2.
10. Yue X, Zang QC. Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases. Ai Zheng. 2004;23(12):1671-6.
11. Postmus PE, Smit EF, Haaxma-Reiche H. Treatment of central nervous system metastases from small cell lung cancer with chemotherapy. Lung Cancer. 1993;9:281-6.
12. Postmus PE, Haaxma-Reiche H, Smit EF, et al. Whole brain radiotherapy used in addition to teniposide has a higher response rate for cerebral metastasis from small-cell lung cancer but no influence on survival rates compared to teniposide alone. Evidence-based Oncol. 2001;2:105-6.
13. Liu M, Zhou Y, Han Q, et al. Whole brain radiotherapy concomitant or sequential Vm26/DDP in treating small cell lung cancer patients with brain metastases. Chin-Ger J Clin Oncol Jan. 2010;9(1):17-21.
14. Postmus PE, Haaxma-Reiche H, Smit EF, et al. Treatment of brain metastases of small-cell lung cancer: Comparing teniposide and teniposide with whole-brain radiotherapy-A phase III study of the European organization for the research and treatment of cancer lung cancer cooperative group. J Clin Oncol. 2000;18: 3400-8.
15. Grossi F, Scolaro T, Tixi L, et al. The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer. Crit Rev Oncol Hematol. 2001;37:61-7.
16. Kochhar R, Frytak S, Shaw EG. Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosis. Am J Clin Oncol. 1997;20(2):125-7.
17. van Hazel GA, Scott M, Eagan RT. The effect of CNS metastases on the survival of patients with small cell cancer of the lung. Cancer. 1983;51(5):933-7.
18. Postmus PE, Haaxma-Reiche H, Gregor A, et al. Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol. 1998;46:29-32.
19. Giannone L, Johnson DH, Hande KR, et al. Favorable prognosis of brain metastases in small cell lung cancer. Ann Intern Med. 1987;106:386-9.
20. Ihde DC, Makuch RW, Carney DM, et al. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis. 1981;123:500-7.
21. Schild SE, Bonner JA, Shanahan TG, et al. Long-term results of a phase III trial comparing once-daily radiotherapy with twicedaily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59(4):943-51.
22. Turrisi AT III, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340(4):265-71.
23. Paumier A, Péchoux CL. Radiotherapy in small-cell lung cancer: where should it go? Lung Cancer. 2010;69:133-40.
24. Schwer AL, Gaspar LE. Update in the treatment of brain metastases from lung cancer. Clin Lung Cancer. 2006;8(3):180-6.
25. Demedts IK, Vermaele KY, van Meerbeeck JP. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects. Eur Respir J. 2010;35:202-5.
26. Stupp R, Monnerat C, Turrisi AT III, et al. Small cell lung cancer: state of the art and future perspectives. Lung Cancer. 2004;45: 105-17.
27. Puglisi M, Dolly S, Faria A, et al. Treatment options for small cell lung cancer -do we have more choice? Br J Cancer. 2010;102: 629-38.